Search
Menu
Home
HTB
2018
November
November 2018
Contents
Editorial
13 November 2018: vol 19 no 17: HIVR4P and Glasgow conferences: first reports
Conference reports
Glasgow HIV Congress (2018)
No additional neural tube defects with preconception dolutegravir: data from three birth outcome cohorts
Insufficient data on risk of neural tube defects with exposure to elvitegravir or bictegravir exposure during preconception or first trimester
Viral dynamics of dolutegravir-based dual versus triple ART
Ibalizumab: 48-week phase 3 results in 27 participants with MDR HIV
Fostemsavir: 48-week phase 3 results from BRIGHTE study
Dolutegravir non-inferior to low dose efavirenz in real-life African study conducted in Cameroon
3rd HIV Research for Prevention Conference (R4P2018)
How to evaluate PrEP and vaccines: urgency for next generation compounds
Dual bNAb maintains viral suppression for median 21 weeks off-ART
Cabotegravir levels can be detected several years: PK tail to be covered by oral PrEP
3D imaging show HIV infection might establish within hours
bNAbs for HIV prevention: extended-release VRC01, AMP study, 10E8 safety signal and pan-clade challenges
Why U=U does not cover breastfeeding
Antiretrovirals
FDA updates rilpivirine label for use during pregnancy
Treatment access
Activists demand $1 a day access to bedaquiline for MDR TB
Guidelines
EACS guidelines – version 9.1 update (2018)
Side effects
Cannabis-based products for medicinal use: Guidance to clinicians
PDFs
13 November 2018: vol 19 no 17
HTB RSS
Early access
Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV
27 May 2025
US update guidelines for statin use in people living with HIV
26 May 2025
HIV activists in the US call for action in JID and Zachie Achmet brings South African perspective in the Lancet
26 May 2025
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement
22 May 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement
22 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate